All
Results: 44437-44448 of 49336

Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases

Survey Reveals Business Professionals Expect Use of Generative AI Will Drive Sharp Increase in Volume of Data and Insights Incorporated Into Business Operations

Beyond Technologies, a Syntax company, establishes new Center of Excellence in Morocco to support global business with local talent

VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML
